Preclinical Studies

TrovaGene Inc (NASDAQ: TROV) is having a great start to the trading session this morning, trading up more than 18% after announcing positive preclinical data further validating its work with Onvansertib. TrovaGene is a company that I’ve followed closely. If you’re unfamiliar with their work, consider reading my full report here. Nonetheless, the data that […]

The European Medicines Agency has granted orphan drug designation to Emerald Health Pharmaceuticals’  lead cannabis-based product for treating systemic scleroderma. EHP-101 is derived from cannabidiol, a chemical found in the cannabis plant. The therapy activates the cell-surface receptors PPARγ and CB2, which in turn activate cell signaling pathways that can help  people with tissue-scarring conditions, multiple sclerosis […]

Emerald Health’s lead cannabinoid-derived investigational therapy, EHP-101, shows promise as a possible oral treatment for scleroderma, a mouse study shows. A second cannabinoid-derivative, called VCE-004.3, also showed potential to enhance anti-inflammatory and anti-fibrotic responses in animal models of scleroderma. Both EHP-101 and VCE-004.3 are derived from cannabidiol (CBD), one of the natural chemicals extracted from […]

Prospector Partners Llc increased Torchmark Corp (TMK) stake by 30.15% reported in 2019Q1 SEC filing. Prospector Partners Llc acquired 52,650 shares as Torchmark Corp (TMK)’s stock rose 5.05%. The Prospector Partners Llc holds 227,250 shares with $18.62M value, up from 174,600 last quarter. Torchmark Corp now has $9.80B valuation. The stock increased 0.27% or $0.24 […]

As the number of states legalizing cannabis as pain relief for cancers like lymphoma and other medicinal and recreational purposes increases, researchers published a report to help clinicians guide patient use. The report, “Contemporary Routes of Cannabis Consumption: A Primer for Clinicians,” was published in The Journal of the American Osteopathic Association. The two main […]

Researchers have demonstrated the potential of a new class of drugs for the treatment of refractory chronic obstructive pulmonary disease, i.e. COPD. Incurable to date, the disease is one of the most frequent causes of death worldwide and is typically triggered by smoking. In the current preclinical study, two anti-inflammatory substances have proved more effective […]

Researchers have demonstrated the potential of a new class of drugs for the treatment of refractory chronic obstructive pulmonary disease, i.e. COPD. Incurable to date, the disease is one of the most frequent causes of death worldwide and is typically triggered by smoking. In the current preclinical study, two anti-inflammatory substances have proved more effective […]

Dietary fiber increases survival in influenza-infected mice by setting the immune system at a healthy level of responsiveness, according to a preclinical study published May 15th in the journal Immunity. A high-fiber diet blunts harmful, excessive immune responses in the lungs while boosting antiviral immunity by activating T cells. These dual benefits were mediated by […]

Dietary fiber increases survival in influenza-infected mice by setting the immune system at a healthy level of responsiveness, according to a preclinical study published May 15th in the journal Immunity. A high-fiber diet blunts harmful, excessive immune responses in the lungs while boosting antiviral immunity by activating T cells. These dual benefits were mediated by […]